B Acute Lymphoblastic Leukemia — Trials

B Acute Lymphoblastic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

345 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 151
Recruiting: 94
Ph III recruiting: 11
Growth YoY: +11.1%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 45.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (46)

clinicaltrialsPublishedShowing 1–15 of 15 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05262673	NGS-MRD Assessment of Combination Immunotherapies Targeting B-ALL	terminated	Phase 1	10	Shenzhen Geno-Immune Medical InstituteOTHER	1	Aug 24, 2026	clinicaltrials
NCT07556757	A Safety and Efficacy Study of CD-19 t-haNK in Patients With B-cell Acute Lymphoblastic Leukemia	terminated	Phase 1	4	ImmunityBio, Inc.INDUSTRY	1	Aug 19, 2026	clinicaltrials